U.S. Markets open in 8 hrs 13 mins

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.00+0.36 (+2.85%)
At close: 4:00PM EDT
Sign in to post a message.
  • J
    John
    where is that araid moron lol he has to be broke by now he probably contemplating which bridge to jump off of
  • O
    Observer
    $SRNE conversation
    Lisa: "Ariadinvestor is an angel. Do not speak against him or you will be struck down by me .... He has spelled it out for all to see. SRNE is what he predicted gold bags. Look at his post history. He has been here a very very long time. Ariadinvestor is a generous gentle genuine gold bag genius !!" <= Ariadinvestor: This maddens my haters! I swear to God Lisa is not me." Links to Lisa's posts:

    Link 1: https://finance.yahoo.com/quote/SRNE/community?messageId=350f622d-8ead-4318-baac-db8b8cd0af30
    Link 2: https://finance.yahoo.com/quote/SRNE/community?messageId=f2084108-e02c-4429-902f-edb03288e022
    Link 3: https://finance.yahoo.com/quote/AUPH/community?messageId=0fb518b9-9884-4a92-b3ae-8c6f88b79a00

    Lisa: "I will crush any that pretend to be Ariadinvestor." Ariadinvestor: "@Yahoo Admin M/Jt/Sal 👈 You pretend to be me by impersonating me! So Lisa will crush you!"

    Ariadinvestor has posted the following:

    This is how I invest in biotech: 4. LAST BUT NOT LEAST, enjoy my hobby/online-entertainment of taunting/striking back provocateurs; 3. Take it easy at bad times; 2. Have patience; 1. Pick up the right gold bag stocks. AUPH/SRNE's great science & pipeline will shine. Patience is the key to the ultimate success of the investors. Before Ariad was bought out, I had been accumulating its shares for 18.5 years with my belief that its great science & pipeline would shine. Time will let my haters know $SRNE / $AUPH are even big gold bags than $ARIA gold bags. Cheers!

    I don't set stop loss. I don't buy on margin. I don't sell but add more when it pulls back. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me.

    LIT: "So we have new director at AUPH. Dr. Brinda does have very good credentials but her tenure is lacking where this position would normally be offered. My question is I didn't know we had an opening on the board. I have not read the bylaws yet on staffing of the board but it does seem strange. There might be provisions for adding board members if a company/fund/individual...purchase's or has control of a certain amount of stock or interest in said company. By controlling this amount there is provisions to offer a seat on the board. Is this the case here? I don't know, but if you look at the credentials of the board members and management why load up with another me too? Did BMRN buy a seat on the board with the Dr.? And if so, who's interest is she looking our for AUPH or BMRN? Good or bad? I guess we will have to wait and see. Looking forward to hearing others take on this. I think its time for that night cap. Thank You and good night to all."

    God bless $AUPH / $SRNE investors. Short squeeze, short squeeze !

    == The followng is junk:==
    "
    Interesting line in this quotation: "reasonably assured..."

    "R&D expenses decreased to $4.8 million for the third quarter ended September 30, 2020 compared to $17.8 million for the same period in 2019. The decrease is due to a decrease in activities related to clinical trials and exploratory development work and the capitalization of inventory and internal development costs as management believes that approval by the FDA of voclosporin as a treatment for LN was reasonably assured."

    the Bullish Report on Sorrento Therapeutics, Inc.

    https://chart-analysis.tools/SRNE

    Top Gainers in the U.S. Stock Markets 🇺🇸

    https://stockreport.tips/Top-Market-Gainers

    The market expects Sorrento Therapeutics (SRNE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2020. If you want investment ideas from real knowledgeable traders, check them out at the https://investena.today/recommends/exclusive-stock-trading-masterclass/ platform

    "
    Bullish
  • O
    Observer
    Lisa: "Ariadinvestor is a generous gentle genuine gold bag genius !!" Ariadinvestor: {To whoever accuses Lisa is me: Let's swear to God that I would burn in hell if Lisa was me, or the accuser's whole clan old & young including the unborn will burn in hell after dying the most painful deaths. Link to Lisa's praise => https://finance.yahoo.com/quote/AUPH/community?messageId=0fb518b9-9884-4a92-b3ae-8c6f88b79a00 Let's swear to God to set the record straight.

    Lisa says: "Ariadinvestor is an angel. Do not speak against him or you will be struck down by me .... He has spelled it out for all to see. SRNE is what he predicted gold bags. Look at his post history. He has been here a very very long time. Ariadinvestor is a generous gentle genuine gold bag genius !!" Why quoting Lisa's sayings? To madden my haters! I swear to God Lisa is not me. Links to Lisa's posts:

    Link 1: https://finance.yahoo.com/quote/SRNE/community?messageId=350f622d-8ead-4318-baac-db8b8cd0af30
    Link 2: https://finance.yahoo.com/quote/SRNE/community?messageId=f2084108-e02c-4429-902f-edb03288e022
    Link 3: https://finance.yahoo.com/quote/AUPH/community?messageId=0fb518b9-9884-4a92-b3ae-8c6f88b79a00

    A falling knife is sweet. I would catch the AUPH/SRNE falling knives now if my portfolio was not heavily weighted in the 2 stocks. I caught the NK/NIO falling knives @ 1.15/1.99 on 2019-11-08. Sweet! I added 10,000 the SRNE falling knives @ 1.57/1.52 on 2019-11-18. Sweet! I caught the ARIA falling knives @ 0.625/0.80 in 1999-10/2018-12. Sweet! Sweet! ... I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me. I really mean what I'm saying. God bless $SRNE / $AUPH investors. Short squeeze is just a matter of time.

    My $48.50/share ARIA dream was interrupted by Takeda's $24/share buyout & my dream came only half true. 死生有命,富贵在天。人算不如天算!I will buy a bottle of Louis XIII to celebrate & invite all my friends to whom I've recommended SRNE/AUPH when $SRNE quadruples H.C. Wainwright's $30 price target or $AUPH is bought out at $66.28+. Even if my SRNE/AUPH dream comes half true, it will be $60 or $33 per share. It will be better if my AUPH dream comes fully true although I will spend $3,700 for the Louis XIII I promise. I always track what I've said. 言必信! 干杯 Louis XIII when I dream comes true!

    I emailed my friends Sunday, April 2, 2017 10:03 AM: { I have just posted: "... Ariad got a $5.2B ($24/share) buyout from Takeda. What AUPH's share price would be should Aurinia also get a $5.2B buyout?" Replying to my own post, I attached some links about AUPH. This was what I talked to Dr. Hu when he called me last Thursday to teach me about biopsy: I know AUPH could drop to ZERO should the phase 3 clinical trial of the LN drug failed given Aurinia has only one drug with only one indication unlike Ariad that had a wonderful drug discovery platform. Nevertheless, I still dream about it. Once in a while, a pipe dream comes partially true.}

    https://www.reservebar.com/products/louis-xiii-cognac?utm_source=GoogleShoppingFeed&utm_medium=search&utm_campaign=LouisXIII&gclid=EAIaIQobChMIsJyuhLS17gIVCvrICh1tqwyhEAQYASABEgJGk_D_BwE

    @M/Jt 😁 I lost money in AUPH? I started to accumulate AUPH early 2017 when it was at @2.90. I posted on 2017-11-22: "I added 7,001 shares @4.28-4.68 on 11/15/2017; 2000 shrs @5.48 11/14/17; 2000 shrs @5.66 10/26/17; 2000 shrs @5.76 10/24/17; 2000 shrs @5.98 10/23/17; 2000 shrs @6.13 10/20/17; ... 4,000 shrs @5.90 around 8/8/17; & I added ..." * Unlike the shorts/bashers who are liars, I actually do what I say. I was accused of pumping AUPH when Yahoo Admin M shorted it at $3.52 on 10/10/2019. @frenkie C 😁 You need to say again "Araid owns only 99 $AUPH shares."😁

    This is how I invest in biotech: 4. LAST BUT NOT LEAST, enjoy my hobby/online-entertainment of taunting/striking back provocateurs; 3. Take it easy at bad times; 2. Have patience; 1. Pick up the right gold bag stocks. AUPH/SRNE's great science & pipeline will shine. Patience is the key to the ultimate success of the investors. Before Ariad was bought out, I had been accumulating its shares for 18.5 years with my belief that its great science & pipeline would shine. Time will let my haters know $SRNE / $AUPH are even big gold bags than $ARIA gold bags. Cheers!

    I don't set stop loss. I don't buy on margin. I don't sell but add more when it pulls back. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment
    }
    Bullish
  • A
    Ariadinvestor
    Jack: "ARIADINVESTOR- you were there for many of us and performed a selfless service for which I am extremely grateful and will never forget you; G-d bless you!" M: "Evidence for what? I’m just doing my job. You can take your buddy Jack and leave this board. It would simplify my life.." I've invited witnesses to watch this public forum for the evidence. Ryan: "M, please remove all Ariadinvestor's posts. Then terminate his account" after he had sold SRNE and gone short again right before 05/14/2020 when $SRNE was up 158% with a 500+ million volume. LOL! 😁 Ryan is M's alias.

    Link 1: https://finance.yahoo.com/quote/AUPH/community?p=AUPH&messageId=ebd58a89-8666-4cca-8f57-2c2ded7f4886
    Link 2: https://finance.yahoo.com/quote/AUPH/community?p=AUPH&messageId=2429bd9b-e8eb-4a1e-ba38-ed3ef9f7d319

    A falling knife is sweet. I would catch the AUPH/SRNE falling knives now if my portfolio was not heavily weighted in the 2 stocks. I caught the NK/NIO falling knives @ 1.15/1.99 on 2019-11-08. Sweet! I added 10,000 the SRNE falling knives @ 1.57/1.52 on 2019-11-18. Sweet! I caught the ARIA falling knives @ 0.625/0.80 in 1999-10/2018-12. Sweet! Sweet! ... I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me. I really mean what I'm saying. God bless $SRNE / $AUPH investors. Short squeeze is just a matter of time.

    My $48.50/share ARIA dream was interrupted by Takeda's $24/share buyout & my dream came only half true. 死生有命,富贵在天。人算不如天算!I will buy a bottle of Louis XIII to celebrate & invite all my friends to whom I've recommended SRNE/AUPH when $SRNE quadruples H.C. Wainwright's $30 price target or $AUPH is bought out at $66.28+. Even if my SRNE/AUPH dream comes half true, it will be $60 or $33 per share. It will be better if my AUPH dream comes fully true although I will spend $3,700 for the Louis XIII I promise. I always track what I've said. 言必信! 干杯 Louis XIII when I dream comes true!

    I emailed my friends Sunday, April 2, 2017 10:03 AM: { I have just posted: "... Ariad got a $5.2B ($24/share) buyout from Takeda. What AUPH's share price would be should Aurinia also get a $5.2B buyout?" Replying to my own post, I attached some links about AUPH. This was what I talked to Dr. Hu when he called me last Thursday to teach me about biopsy: I know AUPH could drop to ZERO should the phase 3 clinical trial of the LN drug failed given Aurinia has only one drug with only one indication unlike Ariad that had a wonderful drug discovery platform. Nevertheless, I still dream about it. Once in a while, a pipe dream comes partially true.}

    https://www.reservebar.com/products/louis-xiii-cognac?utm_source=GoogleShoppingFeed&utm_medium=search&utm_campaign=LouisXIII&gclid=EAIaIQobChMIsJyuhLS17gIVCvrICh1tqwyhEAQYASABEgJGk_D_BwE

    @M/Jt 😁 I lost money in AUPH? I started to accumulate AUPH early 2017 when it was at @2.90. I posted on 2017-11-22: "I added 7,001 shares @4.28-4.68 on 11/15/2017; 2000 shrs @5.48 11/14/17; 2000 shrs @5.66 10/26/17; 2000 shrs @5.76 10/24/17; 2000 shrs @5.98 10/23/17; 2000 shrs @6.13 10/20/17; ... 4,000 shrs @5.90 around 8/8/17; & I added ..." * Unlike the shorts/bashers who are liars, I actually do what I say. I was accused of pumping AUPH when Yahoo Admin M shorted it at $3.52 on 10/10/2019. @frenkie C 😁 You need to say again "Araid owns only 99 $AUPH shares."😁

    This is how I invest in biotech: 4. LAST BUT NOT LEAST, enjoy my hobby/online-entertainment of taunting/striking back provocateurs; 3. Take it easy at bad times; 2. Have patience; 1. Pick up the right gold bag stocks. AUPH/SRNE's great science & pipeline will shine. Patience is the key to the ultimate success of the investors. Before Ariad was bought out, I had been accumulating its shares for 18.5 years with my belief that its great science & pipeline would shine. Time will let my haters know $SRNE / $AUPH are even big gold bags than $ARIA gold bags. Cheers!

    I don't set stop loss. I don't buy on margin. I don't sell but add more when it pulls back. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me.
    ------------------
    @Yahoo Admin M/Jt/Fake Ariadlnvestor 🤣 You bought NIO @ $39? To madden you, I'd like to tell you I bought NIO/NK @ $1.99/$1.15 on 11
    Bullish
  • O
    Observer
    Jack: “Only a foolish lowlife would demean Ariadinvestor.他的故事是我见过的最真正的赢家. 此人不耍把戏没有太多心机, 甚至可能不是个很有趣的人. 但他是一个真正的赢家. Ariadinvestor's story is the only bona fide winner I have seen. Not much of a player or a wit, maybe not even a very interesting guy, but a real winner. Only a fool would argue with him. He has followers for good reason. Many value him. His advice is sage. He is steadfast and correct, kind of heroic. I never saw him gratuitously attack and namecall."

    Ariadinvestor:
    "
    $AUPH / $SRNE short squeeze is just a mater of time.

    The 75,107,937 shares shorted are the best friends of the true longs. Sooner or later, THE SHORTS WILL BE FORCED TO COVER," I posted on 09/28/20. * SRNE CEO Ji: "My goal is to build Sorrento into a $200 billion company in the next 3 to 5 years." AUPH, Gold Bags; SRNE, Bigger Gold Bags. I don't set stop loss. I don't buy on margin. I don't sell but add more when it pulls back. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me. God bless $SRNE / $AUPH investors. I really mean what I'm saying.

    https://insiderfinancial.com/sorrento-stock-the-mayo-clinic-news-is-a-big-deal/180416/?fbclid=IwAR0Yt2PGw-p6Pr7P_tjc_bI7dS1RG8OoGcDx-Blx1q9LrP9pyXdMeP4Qfr

    Link to Ji's presentation at Riley Oncology Virtual Conference:
    https://www.webcaster4.com/Player/Index?webcastId=39569&g=e319a007-37e0-4ca7-99c2-592072e1500d
    Transcripts:
    https://seekingalpha.com/article/4400090-sorrento-therapeutics-inc-srne-ceo-henry-ji-presents-b-riley-virtual-oncology-conference

    " ...
    Mayank Mamtani

    Okay. I do want to spend some time summarizing all this in terms of what one should what an investor should think about from a data generation standpoint. And maybe just focusing on cancer. We can also touch on the timelines for COVID. But before we go there I have to end the final leg with another platform that you have from the Mayo Clinic, which is ADNIC, right. It's the next generation ADC. So could you just briefly talk about that and then we can go into sort of how your 2021 looks like?

    Henry Ji

    Yes. So as a strategic position all big pharma all biopharma company is all about the combination. Now they have to pull different drugs from different company and putting them together. For example you need a cell therapy pull one from one company and you want the Immune checkpoint PD1, PDL1, you need to go to Merck or you need Roche for PDL1 antibody there you need you know our 15 stuff like this. This different places putting together the combo. The beauty of a Mayo Clinic Technology would call the antibody drug nanoparticle albumin-bound or ADNAB complex immunocomplex. There can be one complex including all of the combination. For example you have a chemo compound paclitaxel. And GOF with ABRAXANE, which is a multibillion dollar drug from Bristol by Celgene and you have the ADNAB and that you're putting antibody on it. The beauty of that to stabilize the complex. They were not just integrated in the bloodstream. So very limited that go to a normal tissue and you have antibody on it. It will go to the -- it was 116 nanometer. They go to only the cancer side, which has a leakage, everything else normal tissue they're not getting because you need below the 60 nanometer.

    Now, with antibody you can have a targeting effect right, for example, the RITUXAN you're targeting CD20. Now the beauty you can put in anti-angiogenesis on it, for example, you can put Avastin on it. So it's an anti-angiogenesis. If you're putting the PDL1 on it, you're not only targeting the solid tumors, which they express the PDL1, you also have a immuno checkpoint the activity that to re-germinate the T cell. Now, if you even further we have innovation, if you put a cytokines on top of that, you can stimulate the T-cell. Now if you have a Hal2 it's only stimulate the T effective cells not stimulate the T-reg. You can have multiple of modality on it. Imagine you can put even the ADC on it. So, for example, you can put a CD38 ADC onto that. Then you have two chemo. One is chemo, one is toxin. Two mechanism of action. Then you have a targeted, you have immuno checkpoints and you have cells. If you're putting the NK cell in combination with all this. So this is one complex achieve all of the combination. This is where all big pharma wants it and we luckily will have exclusive rights to the license from Mayo. They have close to 200 patent issued and application pending. So we're dominating on this space. This is the next generation.

    Mayank Mamtani

    Okay.

    Henry Ji

    People will be very excited.

    Mayank Mamtani

    So, maybe as you talk about your -- we didn't even get to oncolytic virus, but we
    Bullish
  • A
    Ariadinvestor
    $SRNE conversation
    SRNE's great science/pipeline is shining! 👍✔ Only true longs will be greatly rewarded. So I added 10,000 shares @$1.57/@$1.52 on 2019-11-18 knowing its great science/pipeline would shine. * ARIA dropped with the market to $0.78 on 2008-12-29. So what? I took the advantage! I added thousands of shares at $0.81/$0.80 although I had lost my job. I swear to God I still held the added shares when Ariad was bought out at $24 on 2017-01-09. No bags, no gold. Long live $SRNE / $AUPH short squeeze! ✔ This is to madden Yahoo Admin M/Jt/Sal.🤣 He impersonates me whenever he's defeated by me. Shame!
    Bullish
  • A
    Ariadinvestor
    @Fred 😊 A falling knife is sweet. I would catch the AUPH/SRNE falling knives now if my portfolio was not heavily weighted in the 2 stocks. I caught the NK/NIO falling knives @ 1.15/1.99 on 2019-11-08. Sweet! I added 10,000 the SRNE falling knives @ 1.57/1.52 on 2019-11-18. Sweet! I caught the ARIA falling knives @ 0.625/0.80 in 1999-10/2018-12. Sweet! Sweet! ... I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. Patience is the key to the ultimate success of a true long's investment. I believe AUPH/SRNE will be my next ARIA. I buy and hold AUPH/SRNE the way I accumulated ARIA gold bags. I always pick up gold bags whenever the price is right to me. No bags, no gold! Traders definitely won't agree with me. Please mute me. I really mean what I'm saying. God bless $SRNE / $AUPH investors. Short squeeze is just a matter of time.
    Bullish
  • A
    Ariadinvestor
    On 10/10/2019, Jack T: "Most of my post thanking ariad for not letting me lose faith the last 2 years were deleted. All in with ariadinvestor and ILJin!!!" Jack: "ARIADINVESTOR- Hang in there buddy..." Me: "The 2 Jacks' posts were deleted by Yahoo Admin M. @M - I don't claim I have huge internet following, but quite a few of my followers are still showing on $AUPH board although you've deleted Jack & Jack T's posts." $AUPH / $SRNE short squeeze is just a matter of time.
    Bullish
  • A
    Ariadinvestor
    Jack T: "No bags no gold! Greatest line ever posted on message board! They always delete Ariadinvestor's posts. I enjoy them." => https://finance.yahoo.com/quote/AUPH/community?messageId=5182cb55-a129-45a4-ba67-884a502ca272 Thanks, Jack! I haven't seen you here for a long time. How are you doing?

    On 10/10/2019, Jack T: "Most of my post thanking ariad for not letting me lose faith the last 2 years were deleted. All in with ariadinvestor and ILJin!!!" Jack: "ARIADINVESTOR- Hang in there buddy..." Me: "The 2 Jacks' posts were deleted by Yahoo Admin M. @M - I don't claim I have huge internet following, but quite a few of my followers are still showing on $AUPH board although you've deleted Jack & Jack T's posts." $AUPH / $SRNE short squeeze is just a matter of time.
    Bullish
  • A
    Ariadinvestor
    @Shibby 👈 I fight back where I'm attacked. Pls feel free to hate/mute/report me, get driven off, or join my enemy Yahoo Admin M/Jt/Sal to attack me. I tell truths about the stocks I own & disclose the evil Yahoo Amin. My hobby/online entertainment is to defeat/taunt my enemy/provocateurs. To Whom It May Concern: My posts are for my enemy M/Jt/Sal or for nice people with high IQ such as Jack, Singer, TwoScoops, K Smooth, Moeman34, Don Austin, Dan, johnny, H.Scott, Joao, Kurt, Shirts vs Blouses, Lisa, Jack T, charles, T, cyaaa, Sandeman, Edward, Terry, Vinh, Levon, robin & Frank who appreciate my posts, which are not for morons like you. Why do you read them? Pls feel free to hate/mute/report me or get driven off this MB by my posts that annoy you. You don't need to get involved.

    God bless $AUPH / $SRNE investors. short squeeze is just a matter of time.

    Larry: "Aurinia Pharmaceuticals: New Data Leads To Revamped Valuation Model
    May 30, 2021 8:00 AM ETAurinia Pharmaceuticals Inc. (AUPH)23 Comments20 Likes
    Summary
    AUPH recently released long-term data for its lupus nephritis drug LUPKYNIS.
    It also hosted an earnings call to go over the first two months of sales data.
    I use all of this new information to revise my sales estimates and stock target price.
    Time for my daily boost
    Photo by ljubaphoto/E+ via Getty Images
    In my last article covering Aurinia Pharmaceuticals (AUPH), which was published coincident with the launch of LUPKYNIS, I built an initial valuation model based on estimated sales and other factors. Since that time, new data, including early sales numbers, has come out which I will review today and then use to revamp my model. In particular, I'll review new longer-term safety & efficacy data for LUPKYNIS and important information provided during the most recent earnings call, and then I'll rebuild my valuation model. Let's get started.

    New LUPKYNIS Long-Term Safety and Efficacy Data
    On May 20, 2021, AUPH announced that it would be presenting "a supportive interim analysis of its AURORA 2 continuation study" at the upcoming European Alliance of Associations for Rheumatology (EULAR) 2021 Congress June 2-5, 2021.

    We'll have to wait till June for all the details, but the PR contained a high level summary of the data which is quite impressive (with my emphasis):

    An interim analysis of the 216 blinded AURORA 2 study subjects (116 voclosporin; 100 control arm) was performed as part of the US New Drug Application. Data from 124 subjects (73 voclosporin; 51 control arm) who had received 104 weeks of continuous treatment was analyzed. Proteinuria continued to improve with a greater reduction in UPCR from pre-treatment baseline to year two observed in the voclosporin arm compared to the control arm (-3.1 vs -2.1 mg/mg; p=0.0004). A greater reduction in proteinuria between arms was also observed between 1 and 2 years (1.0 vs 0.6 mg/mg; voclosporin vs control). Renal function as determined by eGFR remained stable over 104 weeks in both groups compared to baseline assessments. Mean eGFR: 79.6 vs 79.0 mL/min for the voclosporin arm and 78.9 vs 82.9 mL/min for the control arm.

    Additionally, there were no unexpected new AEs observed in patients who continued with voclosporin treatment compared to control-treated patients for more than one year.

    I believe that this data represents another very important step in the successful commercialization of LUPKYNIS (formerly known as voclosporin). Up until now, there was concern that long-term usage might cause renal damage, but this data puts that worry to bed.

    As I discuss below, the safety data also has positive ramifications for my valuation model. Previously I assumed that all patients would discontinue LUPKYNIS after a year of use in order to avoid any longer-term renal problems, but the new data means that many patients will remain on therapy for more than a year.

    The second positive from the AUPH PR is that UPCR continued to be reduced in the second year of LUPKYNIS usage which means that LUPKYNIS' two year efficacy will be much better than competitor Benlysta. Recall this efficacy table from my earlier article.

    We now know that the 80 week and 104 week LUPKYNIS data points (currently shown as n/a) will be better than the 52 week data and hence will be 1.5X to 2X better than Benlysta. Hopefully the actual values will be included in the forthcoming June scientific presentation.

    Whatever the actual values, they will represent another major advantage over Benlysta and will thereby increase LUPKYNIS usage and adoption rates. This new data is also favorable compared to my initial model.

    Now let's turn to information gleaned from the most recent earnings call.

    Takeaways from Earnings Call
    The entire earnings call was of interest (so I recommend that any long-term investor listen to/read the whole thing) but here I will focus on just two very important observations that were made.

    Effect of Covid on Sales
    The first point is that initial sales have been greatly .
    Bullish
  • A
    Ariadinvestor
    I am not responsible for causing mental disorders for anyone who hates my posts but hesitates to mute me, report me to Yahoo or choose to be driven off this message board. I tell truth about SRNE/AUPH by presenting facts & by joking about my enemy & the provocateurs. Taunting them is my online entertainment, which may affect certain people's mental states. The more you hate my posts, the more I post them. I accumulate $AUPH / $SRNE gold bags the way I accumulated ARIA gold bags. No bags no gold!
    Bullish
  • A
    Ariadinvestor
    $SRNE conversation
    I posted 2 months ago: "Added/Bought SRNE @ 6.906, 7.66 & 8.365 for son's Roth IRA on 4/12, 4/7 & 4/1. I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags? Ah? AUPH/SRNE has very bright future. I believe AUPH/SRNE will be my next ARIA. I always pick up gold bags whenever the price is right to me. Traders definitely won't agree with me. Please mute me. Long live $SRNE / $AUPH short squeeze ! "
    Bullish
  • A
    Ariadinvestor
    $SRNE conversation
    @Disciplined_Investing/Sal/M/Jt 😫 You short a life-saving company & badmouthing its CEO. God will punish your entire clan, so your whole clan old & young including the unborn will burn in hell after dying the most painful deaths even SRNE's RTX won't stop you lowlife creeps' pains. God bless SRNE/AUPH investors because investing in life-saving companies is doing good deeds.

    $AUPH short squeze ! $SRNE short squeeze !
    Bullish
  • J
    JACK
    I did it!

    s-auph
    b-srne

    too much upside though auph still a good stock!
  • J
    JACK
    I often wonder what I will do until I do it, but really thinking about cashing out auph for srne.........
  • O
    Observer
    Singer: "I became a millionaire in 2021, thanks to Ariadinvestor and his unfailing support for AUPH! Now holding on for an even bigger payoff with SRNE!!!" https://finance.yahoo.com/quote/SRNE/community?messageId=fe4a537f-4b98-47f5-9f87-f0fcc991fcde&replyId=07969322-ace3-4a3b-8de9-b458bbf4e010 Wayne is dead wrong saying everyone mutes Ariadinvestor.

    Wayne is dead wrong saying everyone mutes Ariadinvestor. At least Singer does not mute Ariadinvestor.

    Ariadinvestor: "Those who listen to me and buy & hold the AUPH/SRNE gold bags will make big money as it has been proven that those who listened to me and bought & held the ARIA gold bags have made big money. Peter Lynch: 'If you like a stock at $14 and it goes to $6, that's good if you understand the company. Take advantage of these declines.' Long live $SRNE / $AUPH short squeeze !"
    Bullish
  • C
    Chip
    The ode to AUPH after a dreary week in the markets: June 18, 2021

    Starting at 3:51 p.m. AUPH became under accumulation with volume bar spikes averaging about 75,000 shares per 1-minute tick. There was a MOC order for a 2 million share block bought at the close at exactly 4:00 p.m. at $13.00. On Monday, June 14, 2021, AUPH announced effective today the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., was appointed to the Company’s Board of Directors effective June 14, 2021 (the same day).

    At BioMarin, Dr. Balakrishnan leads initiatives on corporate strategy, mergers, and acquisitions, partnering, and licensing. Deloitte wrote on June 15, 2021, "As businesses slowly start opening up and moving towards pre-COVID-19 growth levels, Mergers and Acquisitions (M&A) are also gradually reviving. As per the latest M&A trends survey conducted by Deloitte, 61 percent of US dealmakers expect M&A activity to return to pre-COVID-19 levels within the next 12 months.

    According to Investopedia, “Once an (M&A) agreement between two companies is reached, and the due diligence finalized, both companies will decide on the final type of sale. The companies will determine if a sale will be made through the purchase of assets or through the purchase of stock. The acquirer will then finalize its financing arrangement for the purchase.”

    Merger Monday is a term invented by Wall Street to denote the fact that major players in the market often finalize major mergers and acquisitions during the weekend and announce them on Monday. The goal for Monday announcements is to help sway stock prices in favor of the companies making major plays in the market.

    Will AUPH announce a merger on Monday, June 21, 2021? I have no idea. Maybe, maybe not. Here are 5 facts I do know.

    • On May 6th Seeking Alpha wrote, “AUPH rose 5.5% in premarket trading on some speculation about potential takeover interest. AZN and GSK are speculated to be interested in Aurinia, according to The London Times. The newspaper says there are 'whispers' that the AZN and GSK are 'sniffing around' AUPH."

    • On June 14th, AUPH appointed an M.D., who also has a Ph.D., that in her current Biotech position “leads initiatives on corporate strategy, mergers and acquisitions, partnering and licensing.”

    • On June 15th Deloitte, as one of the Big Four accounting organizations and the largest professional services network in the world by revenue and number of professionals, with headquarters in London, England, announced on their website, “Mergers and Acquisitions (M&A) are also gradually reviving.”

    • On June 18th, AUPH experienced material share accumulation starting 9 minutes before the close (Does somebody know something?).

    • GSK, AZN, Deloitte, & The Times are all located in London (Coincidental? Maybe, maybe not).

    Will AUPH and a merger partner be announced on Monday? I have no idea. Maybe, maybe not. Could due diligence have been completed and final M&A terms are now being negotiated? Maybe, maybe not. Was Dr. Balakrishnan selected by AUPH's Board for immediate advisory to maximize shareholder value? Maybe, maybe not.

    Regardless, there was a lot of buying of AUPH's security starting at 3:51 p.m. ET into today's close with somebody ponying up $26 million in the common. Who has the type of money to do that amount of purchases and why did they buy the stock?
    Bullish
  • C
    Chip
    EARLY EDITION - Pre Market Catalyst Event Extract: Saturday, June 19, 2021, 06:31 a.m. ET

    Wednesday - June 23, 2021, 8:00 a.m. ET - GlaxoSmithKline plc (GSK) CEO Emma Walmsley and other execs host a virtual investor event. The update will provide a clear view of the strategy for New GSK, its outlook for growth and the opportunities the company sees for shareholder value creation. On May 6th Seeking Alpha wrote, “AUPH rose 5.5% in premarket trading on some speculation about potential takeover interest. AZN and GSK are speculated to be interested in Aurinia, according to The London Times. The newspaper says there are 'whispers' that the AZN and GSK are 'sniffing around' AUPH."
  • C
    Chip
    Pre Market Catalyst Event Extract: Saturday, June 19, 2021, 07:27 a.m. ET

    Wednesday - June 23, 2021, 8:00 a.m. ET - GlaxoSmithKline plc (GSK) CEO Emma Walmsley and other execs host a virtual investor event. The update will provide a clear view of the strategy for New GSK, its outlook for growth and the opportunities the company sees for shareholder value creation. On May 6th Seeking Alpha wrote, “AUPH rose 5.5% in premarket trading on some speculation about potential takeover interest. AZN and GSK are speculated to be interested in Aurinia, according to The London Times. The newspaper says there are 'whispers' that the AZN and GSK are 'sniffing around' AUPH."

    Question: What information will GSK CEO Emma Walmsley provide to investors on Wednesday on her "clear view of the strategy for New GSK, its outlook for growth and the opportunities the company sees for shareholder value creation?"
    Bullish
  • I
    I strike back 100 times
    @Wayne 😁 You don't care? You are not mad? You can't hide your madness. 🤣 Taunting provocateurs is my online entertainment/hobby, which may affect certain people's mental states. I'm not responsible for causing mental disorders/instability for anyone who hates my posts but hesitates to mute me, report me or go away. The more you hate my posts, the more I post. I strike back/hunt down any provocateurs although I don't provoke anyone. $SRNE / $AUPH short squeeze ?
    Bullish
  • L
    LIT
    So we have new director at AUPH. Dr. Brinda does have very good credentials but her tenure is lacking where this position would normally be offered. My question is I didn't know we had an opening on the board. I have not read the bylaws yet on staffing of the board but it does seem strange. There might be provisions for adding board members if a company/fund/individual...purchase's or has control of a certain amount of stock or interest in said company. By controlling this amount there is provisions to offer a seat on the board. Is this the case here? I don't know, but if you look at the credentials of the board members and management why load up with another me too? Did BMRN buy a seat on the board with the Dr.? And if so, who's interest is she looking our for AUPH or BMRN? Good or bad? I guess we will have to wait and see. Looking forward to hearing others take on this. I think its time for that night cap. Thank You and good night to all.